MEDP (Medpace Holdings) Cash-to-Debt : 5.30 (As of Dec. 2024)

View and export this data going back to 2016. Start your Free Trial

What is Medpace Holdings Cash-to-Debt?

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. Medpace Holdings's cash to debt ratio for the quarter that ended in Dec. 2024 was 5.30.

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. Here we can see, Medpace Holdings could pay off its debt using the cash in hand for the quarter that ended in Dec. 2024.

The historical rank and industry rank for Medpace Holdings's Cash-to-Debt or its related term are showing as below:

MEDP' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.04 Med: 1.01 Max: 5.3
Current: 5.3

During the past 12 years, Medpace Holdings's highest Cash to Debt Ratio was 5.30. The lowest was 0.04. And the median was 1.01.

MEDP's Cash-to-Debt is ranked better than
69.64% of 224 companies
in the Medical Diagnostics & Research industry
Industry Median: 1.23 vs MEDP: 5.30

Medpace Holdings Cash-to-Debt Historical Data

The historical data trend for Medpace Holdings's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

Medpace Holdings Cash-to-Debt Chart

Medpace Holdings Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Cash-to-Debt

Get a 7-Day Free Trial

2.41

3.52

0.15

1.73

5.30

Medpace Holdings Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Cash-to-Debt	Get a 7-Day Free Trial															1.73	2.99	3.88	5.12	5.30

Competitive Comparison of Medpace Holdings's Cash-to-Debt

For the Diagnostics & Research subindustry, Medpace Holdings's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Medpace Holdings's Cash-to-Debt Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Medpace Holdings's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where Medpace Holdings's Cash-to-Debt falls into.

Save Embed

;

Save Embed

;

Medpace Holdings Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

Medpace Holdings's Cash to Debt Ratio for the fiscal year that ended in Dec. 2024 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	669.436	/	(0	+	126.234)
	=	5.30

Medpace Holdings's Cash to Debt Ratio for the quarter that ended in Dec. 2024 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	669.436	/	(0	+	126.234)
	=	5.30

Medpace Holdings (NAS:MEDP) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.

Medpace Holdings Cash-to-Debt Related Terms

Thank you for viewing the detailed overview of Medpace Holdings's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Medpace Holdings Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Medpace Holdings Inc (NAS:MEDP) » Definitions » Cash-to-Debt

Comparable Companies

Traded in Other Exchanges

01P:Germany

Address

5375 Medpace Way, Cincinnati, OH, USA, 45227

Website

https://www.medpace.com

Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical-device firms. It also offers ancillary services such as bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has over 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati and its operations are principally based in the us, but it also operates in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.

Executives

Stephen P Ewald	officer: General Counsel & Corp. Secy.	C/O MEDPACE HOLDINGS,INC., 5375 MEDPACE WAY, CINTINNATI OH 45227
Brian T Carley	director	C/O MEDPACE HOLDINGS, INC., 5375 MEDPACE WAY, CINCINNATI OH 45227
Robert O. Kraft	director	ONE CVS DRIVE, WOONSOCKET RI 02895
Susan E Burwig	officer: Exec. VP, Operations	C/O MEDPACE HOLDINGS, INC., 5375 MEDPACE WAY, CINCINNATI OH 45227
August J. Troendle	director, 10 percent owner, officer: CEO	5375 MEDPACE WAY, CINCINNATI OH 45227
Ashley M. Keating	director	5375 MEDPACE WAY, CINCINNATI OH 45227
Medpace Investors, Llc	10 percent owner	4620 WESLEY AVENUE, CINCINNATI OH 45212
Jesse J Geiger	officer: CFO & COO, Lab Operations	C/O MEDPACE HOLDINGS, INC., 5375 MEDPACE WAY, CINCINNATI OH 45227
Kevin M. Brady	officer: CFO & Treasurer	MEDPACE HOLDINGS, INC., 5375 MEDPACE WAY, CINCINNATI OH 45227
Femida H. Gwadry-sridhar	director	5375 MEDPACE WAY, CINCINNATI OH 45227
Davenport Fred B Jr	director
Mccarthy Cornelius P. Iii	director	5375 MEDPACE WAY, CINCINNATI OH 45227
Tom C King	director	5375 MEDPACE WAY, CINCINNATI OH 45227
Medpace Limited Partnership	10 percent owner	EAST WING, TRAFALGAR COURT, LES BANQUES, ST. PETER PORT, CHANNEL ISLANDS Y7 GY1 3PP
Cinven Capital Management (v) General Partner Ltd	10 percent owner	EAST WING, TRAFALGAR COURT, LES BANQUES, ST. PETER PORT Y7 GY1 3PP